Folgen
Keine Story von Boehringer Ingelheim GmgH mehr verpassen.

Boehringer Ingelheim GmgH

Filtern
  • 23.06.2005 – 13:53

    U.S. FDA Approves New Anti-HIV Drug Aptivus(R) for Use in Combination Therapy

    Ridgefield, Connecticut (ots/PRNewswire) - - The Following Press Release Was Issued By Our U.S. Affiliate Boehringer Ingelheim Pharmaceuticals, Inc. in The United States on June 23, 2005 Boehringer Ingelheim Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration (FDA) has granted accelerated approval of Aptivus(R) (tipranavir) ...